Chemotherapy-Induced Febrile Neutropenia
6 clinical trials · Condition
◉ Watch Chemotherapy-Induced Febrile Neutropenia
| Record | Firm | Date |
|---|---|---|
| Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients (NCT03823950) | University of Mississippi Medical Center | 2019-02-01 |
| Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia (NCT04000711) | Hospital Infantil de Mexico Federico Gomez | 2015-07-01 |
| Efficacy and Safety Study With MYL-1401H and Neulasta (NCT02467868) | Mylan Inc. | 2015-03-01 |
| Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy (NCT02178475) | Amgen | 2014-07-18 |
| Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy. (NCT01813721) | Amgen | 2012-12-01 |
Track Chemotherapy-Induced Febrile Neutropenia automatically
Every clearance here is in the API, with alerts when new ones post.